Pharma industry says UK pricing revenue unsustainable, blocking investments
By Maggie Fick LONDON (Reuters) -The pharmaceutical industry on Thursday blasted the UK government’s levy that aims to curb the national health system’s drugs bill, arguing it is unsustainable and is halting companies from making future investments in the country. The Association of the British Pharmaceutical Industry, including big pharma companies AstraZeneca, Roche and Pfizer, …
Pharma industry says UK pricing revenue unsustainable, blocking investments Read More »







